Corcept Therapeutics Inc Earnings

Corcept Therapeutics Inc’s revenue jumped 7.09% since last year same period to $157.21Mn in the Q1 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated -13.57% fall in its revenue since last 3-months.

Corcept Therapeutics Inc’s net profit fell -26.92% since last year same period to $20.29Mn in the Q1 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated -33.24% fall in its net profits since last 3-months.

Corcept Therapeutics Inc’s net profit margin fell -31.76% since last year same period to 12.9% in the Q1 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated -22.76% fall in its net profit margins since last 3-months.

Corcept Therapeutics Inc’s price-to-earnings ratio after this Q1 2025 earnings stands at 62.07.

Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.14 - a -66.34% fall from last quarter’s estimates.

Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.14.

Corcept Therapeutics Inc’s earning per share (EPS) fell -32.28% since last year same period to 0.17 in the Q1 2025. This indicates that the Corcept Therapeutics Inc has generated -32.28% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Corcept Therapeutics Inc’s return on assets (ROA) stands at 0.09.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Corcept Therapeutics Inc’s return on equity (ROE) stands at 0.22.